Baseline Depressive Symptoms Predict Poor Substance Use Outcome Following Adolescent Residential Treatment
Saved in:
| Title: | Baseline Depressive Symptoms Predict Poor Substance Use Outcome Following Adolescent Residential Treatment |
|---|---|
| Language: | English |
| Authors: | Subramaniam, Geetha A., Stitzer, Maxine A., Clemmey, Philip, Kolodner, Ken, Fishman, Marc J. |
| Source: | Journal of the American Academy of Child & Adolescent Psychiatry. Aug 2007 46(8):1062-1069. |
| Availability: | Elsevier. 6277 Sea Harbor Drive, Orlando, FL 32887-4800. Tel: 877-839-7126; Tel: 407-345-4020; Fax: 407-363-1354; e-mail: usjcs@elsevier.com; Web site: http://www.elsevier.com |
| Peer Reviewed: | Y |
| Page Count: | 8 |
| Publication Date: | 2007 |
| Document Type: | Journal Articles Reports - Research |
| Descriptors: | Risk, Adolescents, Depression (Psychology), Substance Abuse, Regression (Statistics), Models, Evaluation Methods, Intervention, Outcomes of Treatment, Time, Scores, Science Education |
| Assessment and Survey Identifiers: | Beck Depression Inventory |
| DOI: | 10.1097/chi.0b013e31806c7ad0 |
| ISSN: | 0890-8567 |
| Abstract: | Objective: To characterize baseline depressive symptoms among substance-abusing adolescents and determine their association with post residential treatment substance use outcomes. Method: In total, 153 adolescents (mean age 6.6 years, plus or minus 0.11) entering residential treatment were assessed at intake and at 3, 6, 9, and 12 months. Beck Depression Inventory (BDI) and Global Appraisal of Individual Needs were administered to assess depression, other risk factors, and substance use. A regression model was developed with 10 risk factors including BDI scores of greater than or equal to 11 versus less than 11 to predict the outcome measure mean percentage of days in the past 90 days with any (nonnicotine) substance use. Results: At intake, 55% had BDI scores of greater than or equal to 11. A baseline BDI score of greater than or equal to 11 was significantly associated with greater mean percentage of days of substance use (27.5 plus or minus 3.8% versus 15.4 plus or minus 4.0% days, p less than 0.01) across 1-year follow-up. Two other factors were significant: length of drug career greater than 2 years and having an opioid use disorder. Conclusions: Results from this prospective study, although preliminary, suggest the association of depressive symptoms with poorer substance outcomes and the utility of the BDI as a prognostic tool. They highlight the need for interventions targeting co-occurring depressive symptoms that may improve adolescent substance treatment outcomes. (Contains 2 tables and 1 figure.) |
| Abstractor: | As Provided |
| Entry Date: | 2011 |
| Accession Number: | EJ944788 |
| Database: | ERIC |
| Abstract: | Objective: To characterize baseline depressive symptoms among substance-abusing adolescents and determine their association with post residential treatment substance use outcomes. Method: In total, 153 adolescents (mean age 6.6 years, plus or minus 0.11) entering residential treatment were assessed at intake and at 3, 6, 9, and 12 months. Beck Depression Inventory (BDI) and Global Appraisal of Individual Needs were administered to assess depression, other risk factors, and substance use. A regression model was developed with 10 risk factors including BDI scores of greater than or equal to 11 versus less than 11 to predict the outcome measure mean percentage of days in the past 90 days with any (nonnicotine) substance use. Results: At intake, 55% had BDI scores of greater than or equal to 11. A baseline BDI score of greater than or equal to 11 was significantly associated with greater mean percentage of days of substance use (27.5 plus or minus 3.8% versus 15.4 plus or minus 4.0% days, p less than 0.01) across 1-year follow-up. Two other factors were significant: length of drug career greater than 2 years and having an opioid use disorder. Conclusions: Results from this prospective study, although preliminary, suggest the association of depressive symptoms with poorer substance outcomes and the utility of the BDI as a prognostic tool. They highlight the need for interventions targeting co-occurring depressive symptoms that may improve adolescent substance treatment outcomes. (Contains 2 tables and 1 figure.) |
|---|---|
| ISSN: | 0890-8567 |
| DOI: | 10.1097/chi.0b013e31806c7ad0 |
